home / stock / clsn / clsn news

CLSN News and Press, Celsion Corporation From 03/31/21

Stock Information
Company Name: Celsion Corporation
Stock Symbol: CLSN
Market: NASDAQ
Website: celsion.com
Menu
CLSN CLSN Quote CLSN Short CLSN News CLSN Articles CLSN Message Board
Get CLSN Alerts

News, Short Squeeze, Breakout and More Instantly...
CLSN - CELSION CORPORATION ANNOUNCES $15 MILLION REGISTERED DIRECT OFFERING

LAWRENCEVILLE, NJ, March 31, 2021 (GLOBE NEWSWIRE) -- Celsion Corporation (NASDAQ: CLSN) (“Celsion” or the “Company”), today announced it has entered into definitive agreements with institutional investors for the purchase and sale of 11,538,462 shares of it...
CLSN - Banco Bilbao Vizcaya Argentaria, RLX Technology among premarket losers' pack

RLX Technology (RLX) -40%.Takung Art (TKAT) -16%.Turkcell Iletisim Hizmetleri (TKC) -14%Farmmi (FAMI) -13% on proposed underwritten public offering of ordinary shares.Yunji (YJ) -11% on Q4 earnings release.SenesTech (SNES) -10%.Banco Bilbao Vizcaya Argentaria (BBVA) -6%.Or...

CLSN - Celsion Corporation (CLSN) CEO Michael Tardugno on Q4 2020 Results - Earnings Call Transcript

Celsion Corporation (CLSN) Q4 2020 Earnings Conference Call March 19, 2021 11:00 AM ET Company Participants Kim Golodetz - Investor Relations Michael Tardugno - Chairman, CEO and President Jeff Church - Chief Financial Officer Khursheed Anwer - Chief Science Officer Nicholas Borys - Chief Med...

CLSN - Celsion shares fall 8% despite earnings beat

Despite reporting EPS this morning for 2020 that beat analyst expectations and revenue that was in-line, Celsion (CLSN) shares are struggling this afternoon.The company says that its phase 1/2 OVATION 2 study for its ovarian cancer immunotherapy GEN-1 is one-third complete with enrollmen...
CLSN - Celsion EPS beats by $0.06, revenue in-line

Celsion (CLSN): FY GAAP EPS of -$0.67 beats by $0.06.Revenue of $0.5M in-line (flat Y/Y).Shares +1.32% PM.Press Release For further details see: Celsion EPS beats by $0.06, revenue in-line

CLSN - Celsion Corporation Reports 2020 Financial Results and Provides Business Update

Entered 2021 with a Focus on Cancer Immunotherapy and Next-Generation Infectious Vaccines and a Strong Balance Sheet Conference Call Begins at 11:00 a.m. Eastern Time Today LAWRENCEVILLE, N.J., March 19, 2021 (GLOBE NEWSWIRE) -- Celsion Corporation (NASDAQ: CLSN) ...

CLSN - Celsion Corporation to Hold Year-End 2020 Financial Results and Business Update Conference Call on Friday, March 19, 2021

LAWRENCEVILLE, N.J., March 12, 2021 (GLOBE NEWSWIRE) -- Celsion Corporation (NASDAQ: CLSN) , a clinical-stage development company focused on DNA-based immunotherapy and next-generation vaccines, announced today that the Company will host a conference call at 11:00 a.m. EDT on Friday...
CLSN - GSX Techedu, Norwegian Cruise Line Holdings leads the premarket losers' pack

Evofem Biosciences EVFM -25% on Q4 earnings release.Super League Gaming (SLGG) -19%.GSX Techedu GSX -15% on Q4 earnings release.T2 Biosystems TTOO -10% on Q4 earnings release.Senseonics Holdings SENS -9% on Q4 earnings release.Aerpio Pharmaceuticals ARP...

CLSN - Poster on Celsion Corporation's Phase I/II OVATION 2 Study to be Presented at the Society of Gynecologic Oncology Virtual Annual Meeting on Women's Cancer

LAWRENCEVILLE, N.J., March 02, 2021 (GLOBE NEWSWIRE) -- Celsion Corporation (NASDAQ: CLSN) , a clinical-stage development company focused on DNA-based immunotherapy and next-generation vaccines, today announced that a poster on the Company’s Phase I/II OVATION 2 Study...

CLSN - Celsion: Still Waiting For Godot

Today, we revisit biotech concern Celsion Corporation for the first time in over a half-decade. The stock still trades right near the $2 level just like it did when we last took a look at this small-cap name in 2015. News flow in 2021 has picked up, so it's time to circle back on ...
Previous 10 Next 10